Literature DB >> 20012589

Apoptosis: a way to maintain healthy individuals.

Chiara Mondello1, A Ivana Scovassi.   

Abstract

Apoptosis, the best known form of programmed cell death, is tightly regulated by a number of sensors, signal transducers and effectors. Apoptosis is mainly active during embryonic development, when deletion of redundant cellular material is required for the correct morphogenesis of tissues and organs; moreover, it is essential for the maintenance of tissue homeostasis during cell life. Cells also activate apoptosis when they suffer from various insults, such as damage to DNA or to other cellular components, or impairment of basic processes, such as DNA replication and DNA repair. Removal of damaged cells is fundamental in maintaining the health of organisms. In addition, apoptosis induction following DNA damage is exploited to kill cancer cells. In this chapter we will review the main features of developmental and induced apoptosis.

Entities:  

Mesh:

Year:  2010        PMID: 20012589     DOI: 10.1007/978-90-481-3471-7_16

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  12 in total

1.  Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.

Authors:  Xiefeng Wang; Lili Huang; Yanjie Xu; Zhumei Shi; Yingyi Wang; Junxia Zhang; Xirui Wang; Lei Cao; Hui Luo; Jiawei Chen; Ning Liu; Yongmei Yin; Yongping You
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

2.  The biology of aging and frailty.

Authors:  Neal S Fedarko
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

Review 3.  The Apoptosis Paradox in Cancer.

Authors:  Ornella Morana; Will Wood; Christopher D Gregory
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

4.  Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies.

Authors:  Lei Xu; Xin Zhou; Lin Xu; Rong Yin
Journal:  Tumour Biol       Date:  2013-10-05

5.  UNC51-like kinase 1 as a potential prognostic biomarker for hepatocellular carcinoma.

Authors:  Hongtao Xu; Hong Yu; Xiaoyan Zhang; Xiaoying Shen; Kehao Zhang; Haihui Sheng; Shengbin Dai; Hengjun Gao
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

Review 6.  Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis.

Authors:  Yan Liu; Lin Li; Haiyan Qi; Yan Gao; Sha Liu; Chongan Xu
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

7.  RASSF1 Polymorphisms in Cancer.

Authors:  Marilyn Gordon; Mohamed El-Kalla; Shairaz Baksh
Journal:  Mol Biol Int       Date:  2012-05-31

8.  Modulator of Apoptosis 1: A Highly Regulated RASSF1A-Interacting BH3-Like Protein.

Authors:  Jennifer Law; Victor C Yu; Shairaz Baksh
Journal:  Mol Biol Int       Date:  2012-06-14

9.  Autophagy and cancer.

Authors:  Francesca Aredia; Luis Miguel Guamán Ortiz; Vincenzo Giansanti; A Ivana Scovassi
Journal:  Cells       Date:  2012-08-13       Impact factor: 6.600

10.  Current understanding of the Trypanosoma cruzi-cardiomyocyte interaction.

Authors:  Claudia M Calvet; Tatiana G Melo; Luciana R Garzoni; Francisco O R Oliveira; Dayse T Silva Neto; Maria N S L; L Meirelles; Mirian C S Pereira
Journal:  Front Immunol       Date:  2012-10-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.